Clinical Trial Update: The Effects of Cilnidipine on Metabolic Syndrome Improvement [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining cilnidipine for improvement of metabolic syndrome in hypertensive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Cilnidipine (cilnidipine)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension, Metabolic Syndrome X | Phase 4 | Status: COMPLETED